That shift matters because early-stage rounds often rely on instruments designed for speed. A seed SAFE can look operationally simple, but if the investor is a foreign person, or if foreign money sits behind the investing fund, the company may be building later diligence problems into its cap table from the start.
Executive Summary
- FIRRMA expanded CFIUS jurisdiction to some non-controlling investments in technology, infrastructure, and data businesses.
- Seed-stage SAFEs can fall within CFIUS analysis because the rules treat them as contingent equity interests.
- Board rights, technical information access, and substantive decision rights remain the main jurisdictional triggers.
- CFIUS may request information about indirect foreign investors, including limited partners in investment funds.
- Foreign LP exposure that is not documented early can complicate later financing, customer diligence, and exit processes.
- Founders can reduce risk through narrower investor rights, LP screening, and earlier CFIUS analysis.
How CFIUS moved beyond control deals
CFIUS operates under section 721 of the Defense Production Act, as amended over time, including by the Foreign Investment and National Security Act of 2007. The broader modern expansion came with FIRRMA in 2018.
Treasury regulations effective February 13, 2020 extended review to certain non-controlling investments, as described in Treasury materials.
Those rules matter most for what CFIUS calls TID U.S. businesses, meaning companies involved with critical technology, critical infrastructure, or sensitive personal data. In that setting, a minority investment can still be a covered investment.
It applies if it gives the foreign investor board representation or observer rights, access to material nonpublic technical information, or involvement in substantive decision-making on sensitive matters.
This is the legal change that makes early venture documents important. The question is often not whether a foreign investor controls the company, but whether the investor receives specific rights tied to governance, information, or decision-making.
More Business Articles
Why SAFEs can enter the analysis early
A SAFE, or Simple Agreement for Future Equity, is commonly used before a priced round because it postpones valuation and converts later into equity.
Under 31 C.F.R. § 800.207, however, the CFIUS regulations define a contingent equity interest as an instrument that does not currently constitute an equity interest but is convertible into, or provides the right to acquire, one upon a contingency or defined event.
That definition matters because CFIUS does not always wait for conversion to analyze the transaction. As Blank Rome notes, Treasury regulations allow CFIUS to assess whether rights tied to a contingent equity interest should be treated as if they were already converted.
This assessment is based on factors such as the imminence of conversion, whether the conditions are within the acquiring party's control, and whether the future interest and rights can be reasonably determined at the time of acquisition.
For startups in TID categories, that means a foreign investor's SAFE can matter at issuance, not only at the later priced round. If the instrument or side arrangements provide access to technical reporting, governance participation, or rights that become reasonably predictable on conversion, the deal may move much closer to CFIUS jurisdiction.
The same logic explains why a board-observer right can be consequential in an early-stage company. In a startup working on AI chips, advanced software, or other regulated technology, an observer seat may create access to material nonpublic technical information even if the investor never takes a controlling stake.
What CFIUS may ask about foreign LPs
The investment fund structure does not automatically end the inquiry. Treasury's FAQ states that CFIUS may request follow-up information on all foreign investors involved directly or indirectly in a transaction, including limited partners in an investment fund.
According to Treasury, those requests can include identifying information for indirect foreign investors, their jurisdictions of organization, ultimate ownership, and any governance or contractual rights they may hold.
The same FAQ also says such requests may be made regardless of arrangements that would otherwise limit disclosure of an investor's identity.
That point is important for founders because early financing documents often show only the lead fund, not the fund's underlying backers. A startup may believe it accepted money from a U.S. venture firm, while a later CFIUS review, government customer diligence process, or buyer diligence process asks for a clearer picture of who stands behind that fund.
A 2024 note from Torres Trade Law describes the types of information CFIUS often seeks in practice.
This includes the number and type of LPs, the identities and percentages of investors with 5 percent or more of the fund, percentages linked to countries of concern, and governance or contractual rights investors may hold through fund documents or side letters.
Why early-stage companies feel the risk later
The operational problem for founders is timing. A pre-seed or seed round is usually built for speed, low legal cost, and minimal negotiation. The business consequences of a foreign investor's rights, or of foreign LP exposure inside the fund, may not become visible until later.
They often surface during a later financing, a strategic partnership, a government contract review, or an acquisition process.
That is why cap table quality becomes a diligence issue rather than only a financing issue. A company selling into defense, critical infrastructure, advanced computing, or data-intensive markets may face questions from customers, primes, lenders, or acquirers.
These questions go beyond who owns common stock today and extend to who had access, influence, or visibility earlier in the company's life.
This concern has been a recurring theme in legal guidance since the post-FIRRMA rules took effect. A 2025 analysis from Morgan Lewis says proactive diligence and thoughtful deal structuring are important for venture capital transactions involving sensitive sectors.
A failure to address CFIUS issues can disrupt later financings, acquisitions, or exits.
The result is a practical divide between what is easy to close early and what is easy to defend later. A startup may have no immediate CFIUS filing obligation in a given round, yet still create a record that becomes difficult to explain when a future investor or buyer asks for complete visibility into foreign ownership and investor rights.
The rights that create the most exposure
The recurring triggers are relatively narrow, which is why drafting choices matter. Board seats or observer rights, access to material nonpublic technical information, and involvement in substantive decision-making are the core issues embedded in the regulations and related guidance.
For a founder, that means the most important question is often not the investor's headline check size. The more important question is what legal rights come with the investment.
Specifically, founders must ask whether those rights touch technology development, product roadmaps, sensitive datasets, manufacturing plans, export-controlled work, or strategic decisions in a TID business.
This also explains why some foreign capital creates less risk than other foreign capital. A passive economic interest with no governance role and no information access is different from an instrument that includes board observation, enhanced reporting, protective provisions, or rights that become specific and predictable upon conversion.
The same principle applies at the fund level. A foreign LP that is economically passive presents a different profile from one that has side-letter rights, governance influence, concentrated ownership in the fund, or other features that make the LP relevant to jurisdictional or national security analysis.
What founders and funds can do at the seed stage
The first step is identifying whether the company is plausibly a TID U.S. business. Many startups do not use that label internally.
However, a company working in semiconductors, AI systems with national security relevance, advanced sensors, cybersecurity tools, defense applications, or large-scale sensitive personal data may already be in the part of the market where CFIUS analysis becomes routine.
The second step is narrowing investor rights in the earliest documents. A SAFE that excludes board-observer rights, technical information access, and substantive approval rights is easier to analyze than one paired with side letters, reporting rights, or governance concessions that were added informally during fundraising.
The third step is obtaining better information from funds about foreign investor exposure. Founders will not always receive a full LP list, but they can ask for representations, side-letter limits, passivity confirmations, or other diligence support.
This reduces uncertainty when a later investor, customer, or acquirer asks whether foreign persons had indirect rights or influence.
Where the facts are closer to the line, counsel may recommend a voluntary filing strategy or another structured approach to reduce future uncertainty. The point is not that every startup with a foreign investor needs a filing.
The point is that ignoring the issue at seed stage can make later options narrower and more expensive.
A financing document can become a strategic constraint
In many startups, the SAFE is treated as a temporary instrument that will disappear into the next round. CFIUS analysis cuts against that assumption because the initial grant of rights, the identity of the investor, and the structure of the fund can remain relevant long after the document itself converts or is replaced.
That persistence is what makes early-stage cap table design a strategic issue. A company that hopes to serve defense customers, partner with critical infrastructure operators, or sell to a larger buyer in a sensitive sector may eventually be judged not only on its technology, but also on whether its financing history created unresolved foreign investment questions.
For that reason, the cleanest seed documents are often the most flexible later. A startup that knows who its investors are, limits sensitive rights, and can explain indirect foreign exposure with confidence enters future diligence from a stronger position.
This is far better than trying to reconstruct those facts after the business has matured.
CFIUS does not review every seed round, and foreign capital is not inherently disqualifying. But in sensitive sectors, founders now have stronger reasons to treat investor rights, indirect ownership visibility, and cap table hygiene as part of core company formation rather than as issues reserved for a later financing or exit.
Sources
- U.S. Department of the Treasury. "CFIUS Laws and Guidance." U.S. Department of the Treasury, 2024.
- U.S. Department of the Treasury. "CFIUS Frequently Asked Questions." U.S. Department of the Treasury, 2024.
- Blank Rome LLP. "Is Your SAFE Transaction Safe from CFIUS?." Blank Rome LLP, 2025.
- Olga Torres, Managing Member. "Identities of Investment Fund Limited Partners in CFIUS Reviews." Torres Trade Law PLLC, 2024.
- Morgan Lewis & Bockius LLP. "Key Takeaways: CFIUS and Other Foreign Investor Considerations for Venture Capital." Morgan Lewis & Bockius LLP, 2025.
